BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33098668)

  • 21. Differential effects of PD-1 and CTLA-4 blockade on the melanoma-reactive CD8 T cell response.
    Gangaev A; Rozeman EA; Rohaan MW; Isaeva OI; Philips D; Patiwael S; van den Berg JH; Ribas A; Schadendorf D; Schilling B; Schumacher TN; Blank CU; Haanen JBAG; Kvistborg P
    Proc Natl Acad Sci U S A; 2021 Oct; 118(43):. PubMed ID: 34670835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Checkpoint Blockade Immunotherapy Induces Dynamic Changes in PD-1
    Kurtulus S; Madi A; Escobar G; Klapholz M; Nyman J; Christian E; Pawlak M; Dionne D; Xia J; Rozenblatt-Rosen O; Kuchroo VK; Regev A; Anderson AC
    Immunity; 2019 Jan; 50(1):181-194.e6. PubMed ID: 30635236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Follicular CXCR5- expressing CD8(+) T cells curtail chronic viral infection.
    He R; Hou S; Liu C; Zhang A; Bai Q; Han M; Yang Y; Wei G; Shen T; Yang X; Xu L; Chen X; Hao Y; Wang P; Zhu C; Ou J; Liang H; Ni T; Zhang X; Zhou X; Deng K; Chen Y; Luo Y; Xu J; Qi H; Wu Y; Ye L
    Nature; 2016 Aug; 537(7620):412-428. PubMed ID: 27501245
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune checkpoint status and exhaustion-related phenotypes of CD8
    Yilmaz I; Tavukcuoglu E; Horzum U; Yilmaz KB; Akinci M; Gulcelik MA; Oral HB; Esendagli G
    Cancer Med; 2023 Dec; 12(24):22196-22205. PubMed ID: 38069525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CXCR3 and CXCR5 are highly expressed in HIV-1-specific CD8 central memory T cells from infected patients.
    Olivo A; Lécuroux C; Bitu M; Avettand-Fenoel V; Boufassa F; Essat A; Meyer L; Doisne JM; Favier B; Vaslin B; Schlecht-Louf G; Noël N; Goujard C; Lambotte O; Bourgeois C
    Eur J Immunol; 2021 Aug; 51(8):2040-2050. PubMed ID: 33963550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CXCR5
    Liu Z; Zhao Z; Xie H; Lu N; Liu J; Jiao Q
    Front Immunol; 2024; 15():1295309. PubMed ID: 38426098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CXCR5
    Tyllis TS; Fenix KA; Norton TS; Kara EE; McKenzie DR; David SC; Alsharifi M; Yu D; McColl SR; Comerford I
    Front Immunol; 2021; 12():626199. PubMed ID: 34326833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human Lymph Nodes Maintain TCF-1
    Miron M; Kumar BV; Meng W; Granot T; Carpenter DJ; Senda T; Chen D; Rosenfeld AM; Zhang B; Lerner H; Friedman AL; Hershberg U; Shen Y; Rahman A; Luning Prak ET; Farber DL
    J Immunol; 2018 Oct; 201(7):2132-2140. PubMed ID: 30111633
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV-Specific CD8
    Reuter MA; Del Rio Estrada PM; Buggert M; Petrovas C; Ferrando-Martinez S; Nguyen S; Sada Japp A; Ablanedo-Terrazas Y; Rivero-Arrieta A; Kuri-Cervantes L; Gunzelman HM; Gostick E; Price DA; Koup RA; Naji A; Canaday DH; Reyes-Terán G; Betts MR
    Cell Rep; 2017 Dec; 21(12):3458-3470. PubMed ID: 29262326
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intratumoral CXCR5
    Wang J; Li R; Cao Y; Gu Y; Fang H; Fei Y; Lv K; He X; Lin C; Liu H; Zhang H; Li H; He H; Xu J; Huang H
    Nat Commun; 2021 May; 12(1):3080. PubMed ID: 34035252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The diagnostic role of PD-1
    Fan JW; Yan L; Wang XQ; Li YM; Bai YJ; Ou XQ; Wan ZL; Li Y
    J Clin Lab Anal; 2022 Feb; 36(2):e24200. PubMed ID: 34957609
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mapping the Lineage Relationship between CXCR5
    Del Alcazar D; Wang Y; He C; Wendel BS; Del Río-Estrada PM; Lin J; Ablanedo-Terrazas Y; Malone MJ; Hernandez SM; Frank I; Naji A; Reyes-Terán G; Jiang N; Su LF
    Cell Rep; 2019 Sep; 28(12):3047-3060.e7. PubMed ID: 31533030
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CXCR5+ CD8 T Cells: Protective or Pathogenic?
    Valentine KM; Hoyer KK
    Front Immunol; 2019; 10():1322. PubMed ID: 31275308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CXCR5
    Chen Y; Yu M; Zheng Y; Fu G; Xin G; Zhu W; Luo L; Burns R; Li QZ; Dent AL; Zhu N; Cui W; Malherbe L; Wen R; Wang D
    Nat Commun; 2019 Sep; 10(1):4415. PubMed ID: 31562329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD8+ T-cells Co-expressing PD-1 and TIGIT Are Highly Frequent in Chronic Lymphocytic Leukemia.
    Hajiasghar-Sharbaf R; Asgarian-Omran H; Valadan R; Hossein-Nattaj H; Shekarriz R; Zaboli E; Janbabaei G; Tehrani M
    Iran J Allergy Asthma Immunol; 2021 Dec; 20(6):751-763. PubMed ID: 34920658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Programmed death-1 shapes memory phenotype CD8 T cell subsets in a cell-intrinsic manner.
    Charlton JJ; Chatzidakis I; Tsoukatou D; Boumpas DT; Garinis GA; Mamalaki C
    J Immunol; 2013 Jun; 190(12):6104-14. PubMed ID: 23686498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Self-Renewing CD8+ T-cell Abundance in Blood Associates with Response to Immunotherapy.
    Maniar R; Wang PH; Washburn RS; Kratchmarov R; Coley SM; Saqi A; Pan SS; Hu J; Shu CA; Rizvi NA; Henick BS; Reiner SL
    Cancer Immunol Res; 2023 Feb; 11(2):164-170. PubMed ID: 36512052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progenitor-like exhausted SPRY1
    Liu Z; Zhang Y; Ma N; Yang Y; Ma Y; Wang F; Wang Y; Wei J; Chen H; Tartarone A; Velotta JB; Dayyani F; Gabriel E; Wakefield CJ; Kidane B; Carbonelli C; Long L; Liu Z; Su J; Li Z
    Cancer Cell; 2023 Nov; 41(11):1852-1870.e9. PubMed ID: 37832554
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered levels of circulating CD8
    Zhai X; Wang Y; Guo H; Liang Z; Feng M; Wu Y; Qin Y; Zhao X; Gao C; Luo J
    Clin Rheumatol; 2022 Jun; 41(6):1697-1708. PubMed ID: 35171365
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CXCR5
    Elzein SM; Zimmerer JM; Han JL; Ringwald BA; Bumgardner GL
    J Immunol; 2021 Jun; 206(12):2775-2783. PubMed ID: 34602651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.